The Role of PPARs in Lung Fibrosis
Author Information
Author(s): Heather F. Lakatos, Thomas H. Thatcher, Kottmann R. Matthew, Garcia Tatiana M., Phipps Richard P., Sime Patricia J.
Primary Institution: University of Rochester
Hypothesis
The study investigates the role of peroxisome proliferator-activated receptors (PPARs) in regulating processes related to lung fibrosis.
Conclusion
PPARα and PPARγ agonists have potential as antifibrotic therapies in lung fibrosis.
Supporting Evidence
- PPARα agonists inhibit collagen production in liver and cardiac fibrosis models.
- PPARγ ligands reduce lung fibrosis in animal models.
- PPARα knockout mice develop more severe fibrosis in response to bleomycin.
Takeaway
This study looks at how certain proteins in our body can help prevent lung scarring, which makes it hard to breathe.
Methodology
The review discusses various studies and models related to PPARs and lung fibrosis.
Limitations
The understanding of PPARs in lung fibrosis is limited due to a lack of direct experiments involving lung cells.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website